PALO ALTO, Calif.– Origin Technologies Corporation, LLC (“Origin”), a newly created entity owned by a group of former Affymetrix executives for the purpose of privatizing Affymetrix, Inc. (“Affymetrix”, NASDAQ: AFFX), today issued the following statement:

“We are committed to completing a friendly transaction with Affymetrix and reiterate our offer to acquire all of the company’s outstanding shares for $16.10 per share in cash. Our highly compelling offer provides an opportunity for Affymetrix stockholders to realize additional value through a significantly more attractive premium than the proposed transaction with Thermo Fisher, and we are confident in our ability to close our transaction expeditiously. However, in order to proceed with the transaction between Origin and Affymetrix, we require an opportunity to engage with the Affymetrix Board of Directors to address their concerns and complete confirmatory diligence. We believe it would be in the best interests of all parties for the Affymetrix Board to engage with us without delay.”

About Origin

Origin Technologies Corporation, LLC is owned by a group of former Affymetrix executives, who share a passion and vision for advancing genomics for precision medicine and other critical applications. The entity was formed for the specific purpose of privatizing Affymetrix.

SummitView Capital has committed to provide financing to Origin for the proposed transaction. Covington & Burling LLP is acting as legal advisor to Origin for the proposed transaction.